These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

424 related items for PubMed ID: 26613512

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. In human cell cultures, everolimus is inferior to tacrolimus in inhibiting cellular alloimmunity, but equally effective as regards humoral alloimmunity.
    Eleftheriadis T, Pissas G, Sounidaki M, Antoniadi G, Antoniadis N, Liakopoulos V, Stefanidis I.
    Int Urol Nephrol; 2017 Sep; 49(9):1691-1697. PubMed ID: 28508247
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Epstein-Barr Virus Latent Membrane Protein 2A (LMP2A) Enhances ATP Production in B Cell Tumors through mTOR and HIF-1α.
    Incrocci R, Monroy Del Toro R, Devitt G, Salimian M, Braich K, Swanson-Mungerson M.
    Int J Mol Sci; 2024 Apr 02; 25(7):. PubMed ID: 38612754
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Oscillatory mTOR inhibition and Treg increase in kidney transplantation.
    Sabbatini M, Ruggiero G, Palatucci AT, Rubino V, Federico S, Giovazzino A, Apicella L, Santopaolo M, Matarese G, Galgani M, Terrazzano G.
    Clin Exp Immunol; 2015 Nov 02; 182(2):230-40. PubMed ID: 26077103
    [Abstract] [Full Text] [Related]

  • 29. The dual targeting of insulin and insulin-like growth factor 1 receptor enhances the mTOR inhibitor-mediated antitumor efficacy in hepatocellular carcinoma.
    Pivonello C, Negri M, De Martino MC, Napolitano M, de Angelis C, Provvisiero DP, Cuomo G, Auriemma RS, Simeoli C, Izzo F, Colao A, Hofland LJ, Pivonello R.
    Oncotarget; 2016 Mar 01; 7(9):9718-31. PubMed ID: 26756219
    [Abstract] [Full Text] [Related]

  • 30. Mammalian target of rapamycin inhibition induces cell cycle arrest in diffuse large B cell lymphoma (DLBCL) cells and sensitises DLBCL cells to rituximab.
    Wanner K, Hipp S, Oelsner M, Ringshausen I, Bogner C, Peschel C, Decker T.
    Br J Haematol; 2006 Sep 01; 134(5):475-84. PubMed ID: 16856892
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Review of combination therapy with mTOR inhibitors and tacrolimus minimization after transplantation.
    Peddi VR, Wiseman A, Chavin K, Slakey D.
    Transplant Rev (Orlando); 2013 Oct 01; 27(4):97-107. PubMed ID: 23932018
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Epstein-Barr virus associated Burkitt lymphoma in a heart transplant recipient.
    Hunt BJ, Thomas JA, Burke M, Walker H, Yacoub M, Crawford DH.
    Transplantation; 1996 Sep 27; 62(6):869-72. PubMed ID: 8824493
    [Abstract] [Full Text] [Related]

  • 37. Cyclosporin A inhibits colon cancer cell growth independently of the calcineurin pathway.
    Werneck MB, Hottz E, Bozza PT, Viola JP.
    Cell Cycle; 2012 Nov 01; 11(21):3997-4008. PubMed ID: 22992618
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Dual blockade of the PI3K/Akt/mTOR pathway inhibits posttransplant Epstein-Barr virus B cell lymphomas and promotes allograft survival.
    Sang AX, McPherson MC, Ivison GT, Qu X, Rigdon J, Esquivel CO, Krams SM, Martinez OM.
    Am J Transplant; 2019 May 01; 19(5):1305-1314. PubMed ID: 30549430
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 22.